PeterESchwartzMD
Obstetrics & Gynecology • New Haven, CTGynecologic Oncology
Professor of Obstetrics & Gynecology, Yale University
Dr. Schwartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Howard Ave
Bldg
New Haven, CT 06519Phone+1 203-785-4176Fax+1 203-785-5886
Education & Training
University of Texas Health Science Center at HoustonResidency, Obstetrics and Gynecology, 1974 - 1975
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1973 - 1975
Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1967 - 1971
University of Kentucky College of Medicine (Bowling Green)Internship, Transitional Year, 1966 - 1967
Albert Einstein College of MedicineClass of 1966
Certifications & Licensure
CA State Medical License 1971 - Present
CT State Medical License 1968 - 2025
TX State Medical License 1973 - 1985- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2003-2014
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Publications & Presentations
PubMed
- Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovaria...Levent Mutlu, Blair McNamara, Stefania Bellone, Diego D Manavella, Cem Demirkiran
Clinical & Experimental Metastasis. 2024-10-01 - Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma.Blair McNamara, Michelle Greenman, Stefania Bellone, Luca A Santin, Cem Demirkiran
Gynecologic Oncology. 2024-10-01 - 1 citationsTubal Sterilization Rates by State Abortion Laws After the Dobbs Decision.Xiao Xu, Ling Chen, Vrunda B Desai, Cary P Gross, Craig Evan Pollack
JAMA. 2024-09-11
Journal Articles
- Hospital Variation in Responses to Safety Warnings About Power Morcellation in HysterectomyVrunda B Desai, Peter E Schwartz, American Journal of Obstetrics and Gynecology
Press Mentions
In Memoriam: Peter E. Schwartz, MDOctober 21st, 2024- Study Validates Combination Therapy for Aggressive Endometrial CancerJune 26th, 2020
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
